Prashanth Thevkar Nagesh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coenzyme A Ligases | 1 | 2022 | 45 | 0.820 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2022 | 103 | 0.800 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 325 | 0.670 |
Why?
|
| Hyperglycemia | 2 | 2022 | 1389 | 0.550 |
Why?
|
| NF-kappa B | 1 | 2022 | 2492 | 0.440 |
Why?
|
| Neutrophil Infiltration | 1 | 2024 | 395 | 0.380 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 1026 | 0.300 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2019 | 91 | 0.290 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 133 | 0.250 |
Why?
|
| Inflammation | 4 | 2023 | 10868 | 0.240 |
Why?
|
| Hepatic Stellate Cells | 1 | 2024 | 117 | 0.220 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 856 | 0.220 |
Why?
|
| Neutrophils | 2 | 2024 | 3785 | 0.210 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2023 | 108 | 0.210 |
Why?
|
| Coenzyme A | 1 | 2022 | 39 | 0.200 |
Why?
|
| Fatty Liver | 2 | 2024 | 810 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2019 | 3811 | 0.190 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 179 | 0.190 |
Why?
|
| Liver | 3 | 2024 | 7578 | 0.190 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1282 | 0.180 |
Why?
|
| Cholestasis | 1 | 2023 | 385 | 0.170 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2022 | 162 | 0.170 |
Why?
|
| Down-Regulation | 1 | 2017 | 2942 | 0.170 |
Why?
|
| Indenes | 2 | 2024 | 59 | 0.170 |
Why?
|
| Furans | 2 | 2024 | 202 | 0.160 |
Why?
|
| Virus Replication | 1 | 2016 | 2458 | 0.150 |
Why?
|
| Lipopolysaccharides | 2 | 2022 | 2222 | 0.150 |
Why?
|
| Sulfones | 2 | 2024 | 448 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3840 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 1124 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3941 | 0.130 |
Why?
|
| Monocytes | 1 | 2024 | 2603 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2016 | 1542 | 0.120 |
Why?
|
| Glucose | 2 | 2022 | 4352 | 0.120 |
Why?
|
| Sulfoxides | 1 | 2024 | 47 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 718 | 0.120 |
Why?
|
| Myocardium | 1 | 2017 | 4790 | 0.110 |
Why?
|
| Macrophages | 2 | 2024 | 5801 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 12253 | 0.110 |
Why?
|
| Mice | 7 | 2024 | 82072 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 1550 | 0.090 |
Why?
|
| Sulfonamides | 2 | 2024 | 1981 | 0.090 |
Why?
|
| Animals | 10 | 2024 | 169335 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 22379 | 0.080 |
Why?
|
| Cell Line | 3 | 2019 | 15604 | 0.080 |
Why?
|
| Ventricular Myosins | 1 | 2019 | 65 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2024 | 540 | 0.080 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 1682 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12806 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 404 | 0.070 |
Why?
|
| Ethanol | 2 | 2024 | 1331 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2024 | 1245 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 91 | 0.070 |
Why?
|
| Cell Communication | 1 | 2024 | 1660 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3431 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 306 | 0.060 |
Why?
|
| Myofibroblasts | 1 | 2017 | 230 | 0.060 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 173 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7453 | 0.060 |
Why?
|
| Liver Cirrhosis | 2 | 2024 | 1962 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2024 | 23653 | 0.050 |
Why?
|
| Influenza A virus | 1 | 2016 | 460 | 0.050 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2023 | 146 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2023 | 288 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2016 | 569 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 129 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1608 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 399 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3588 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4592 | 0.040 |
Why?
|
| Fibrosis | 1 | 2017 | 2080 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11932 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2017 | 5033 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 18354 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2022 | 840 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 768970 | 0.030 |
Why?
|
| Diet | 1 | 2024 | 8088 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 5793 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 2149 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 778 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2023 | 8317 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2893 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19023 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 6011 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2022 | 3139 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 22389 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11684 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7058 | 0.020 |
Why?
|
| Apoptosis | 1 | 2023 | 9527 | 0.020 |
Why?
|
| Male | 3 | 2024 | 365203 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 40261 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2022 | 14484 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59739 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13698 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 171786 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 223737 | 0.010 |
Why?
|
| Female | 1 | 2019 | 397515 | 0.010 |
Why?
|